Dr. Brian Biesman sits down with Dermatology Times to talk about the important role surgery plays in eyelid rejuvenation.
Millennials think of aesthetic treatments no differently than other beauty appointments, according to Dr. Ava Shamban. These are their top facial concerns.
In the evolution of skin resurfacing technology, from full-field CO2 to fractional and now fractional plasma, Alma believes theirs is a novel innovation offering versatile skin solutions.
The FDA announced it has accepted a priority review of dupilumab for the treatment of moderate-to-severe AD in pediatric patients 6 to 11 years of age. The drug is already approved for treatment of AD in adolescents and adults.
Medical device company Soliton presents results from their 12-week study looking at the treatment of fibrotic scars via their RAP device at Maui Derm.
Chemical peels offer important advantages for treating melasma. Researchers offer insights from a review of recent advances in chemical peel treatments in melasma and acne.
In a skit depicting Carnac the Magnificent, Drs. Rosen and Bhatia presented on 2020's new drugs and technologies at the current Maui Derm for Dermatologists, all with a magical twist.
Melasma responds well to oral and locally injected tranexamic acid treatments, but clinical results from topical tranexamic acid administration have been disappointing, researchers report. They examined efficacy of a co-enhancer as a method to deliver the treatment.
Investigative cryolipolysis technique holds promise as a new strategy for selective, nonsurgical fat reduction.
Dermatology Times sits down with with program director George Martin, M.D., who highlights hot topics from this year's Maui Dermatology for Dermatologists meeting.